Published in Healthcare Finance, Tax and Law Weekly, December 17th, 2008
The Canadian authorities intend to use IMVAMUNE(R) as part of the country's bio-preparedness programme.
The contract provides for the delivery of 20,000 doses of IMVAMUNE(R) and payment for the application process to support the use of IMVAMUNE(R) in an emergency under the Canadian Government's Special Access Programme. The delivery will take place in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.